307 results on '"Brouwers, Adrienne H."'
Search Results
2. Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography
3. Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations
4. Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT
5. Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial
6. Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
7. EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data
8. Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
9. Convolutional neural networks for automatic image quality control and EARL compliance of PET images
10. Shortened duration whole body 18F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function
11. Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT
12. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
13. First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner
14. Advances and challenges in immunoPET methodology.
15. Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
16. Head-to-head comparison of [11C]methionine PET, [11C]choline PET, and 4-dimensional CT as second-line scans for detection of parathyroid adenomas in primary hyperparathyroidism.
17. Use of population input functions for reduced scan duration whole-body Patlak 18F-FDG PET imaging
18. The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors
19. A Novel and Generic Workflow of Indocyanine Green Perfusion Assessment Integrating Standardization and Quantification Toward Clinical Implementation
20. High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment
21. Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
22. Ultra‐low dose CT scanning for PET/CT.
23. Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms
24. Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
25. Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis
26. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
27. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk
28. Current and Future Use of Long Axial Field-of-View Positron Emission Tomography/Computed Tomography Scanners in Clinical Oncology.
29. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab.
30. The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors.
31. Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT
32. Optimization of parathyroid 11C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism
33. Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT.
34. Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis
35. Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging
36. Volume of interest delineation techniques for 18F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study
37. Lymphatic drainage patterns of oral maxillary tumors: Approachable locations of sentinel lymph nodes mainly at the cervical neck level
38. Additional value of a high sensitive thyroglobulin assay in the follow‐up of patients with differentiated thyroid carcinoma
39. Tailored imaging of islet cell tumors of the pancreas amidst increasing options
40. Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study
41. Shortened duration whole body 18F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function.
42. 89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
43. Progressive diastolic dysfunction in survivors of pediatric differentiated thyroid carcinoma.
44. Bone Marrow Function After 131I Therapy in Patients With Differentiated Thyroid Carcinoma
45. Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy.
46. Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
47. Considerations on absence of 68Ga-DOTA-F(ab′)2-trastuzumab tracer uptake in HER2-overexpressing tumor lesions
48. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.
49. Quality Indicators for the Diagnosis and Management of Primary Hyperparathyroidism.
50. Molecular imaging for monitoring treatment response in breast cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.